[HTML][HTML] Wnt/β-catenin signaling in cancers and targeted therapies

F Yu, C Yu, F Li, Y Zuo, Y Wang, L Yao, C Wu… - … and Targeted Therapy, 2021 - nature.com
Wnt/β-catenin signaling has been broadly implicated in human cancers and experimental
cancer models of animals. Aberrant activation of Wnt/β-catenin signaling is tightly linked with …

[HTML][HTML] Recent progress in treatment of hepatocellular carcinoma

Z Chen, H Xie, M Hu, T Huang, Y Hu… - American journal of …, 2020 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death
worldwide. In the past decade, there have been improvements in non-drug therapies and …

[HTML][HTML] Wnt/β-Catenin signaling as a driver of stemness and metabolic reprogramming in hepatocellular carcinoma

RWH Leung, TKW Lee - Cancers, 2022 - mdpi.com
Simple Summary Aberrant Wnt/β-catenin signaling has been reported to play crucial role in
pathogenesis of hepatocellular carcinoma (HCC). In this review, we focus on the regulatory …

Dual-target inhibitors of PARP1 in cancer therapy: A drug discovery perspective

J Zhang, J Zhang, H Li, L Chen, D Yao - Drug Discovery Today, 2023 - Elsevier
Highlights•Poly [ADP-ribose] polymerase 1 (PARP1) is a promising cancer therapeutic target
for synergistic combinations of drugs.•PARP1 has a direct role in DNA repair for cancer …

[HTML][HTML] Targeting Wnt/β-catenin pathways in primary liver tumours: from microenvironment signaling to therapeutic agents

F Selvaggi, T Catalano, R Cotellese, GM Aceto - Cancers, 2022 - mdpi.com
Simple Summary Human primary liver cancers have a poor prognosis. At present, there are
limited treatment alternatives, and to understand the molecular aspects of liver …

Small-molecule inhibitors of tankyrases as prospective therapeutics for cancer

M Yu, Y Yang, M Sykes, S Wang - Journal of Medicinal Chemistry, 2022 - ACS Publications
Tankyrases are multifunctional poly (adenosine diphosphate-ribose) polymerases that
regulate diverse biological processes including telomere maintenance and cellular …

ZEB1 serves an oncogenic role in the tumourigenesis of HCC by promoting cell proliferation, migration, and inhibiting apoptosis via Wnt/β-catenin signaling pathway

L Li, J Yang, F Rong, Z Luo, S Hu, H Fang… - Acta Pharmacologica …, 2021 - nature.com
Zinc finger E-box-binding homeobox 1 (ZEB1), a functional protein of zinc finger family, was
aberrant expressed in many kinds of liver disease including hepatic fibrosis and Hepatitis C …

[HTML][HTML] Wnt signaling in liver regeneration, disease, and cancer

G Zou, JI Park - Clinical and Molecular Hepatology, 2023 - ncbi.nlm.nih.gov
The liver exhibits the highest recovery rate from acute injuries. However, in chronic liver
disease, the long-term loss of hepatocytes often leads to adverse consequences such as …

[HTML][HTML] Tankyrases as modulators of pro-tumoral functions: molecular insights and therapeutic opportunities

E Zamudio-Martinez, AB Herrera-Campos… - Journal of Experimental …, 2021 - Springer
Abstract Tankyrase 1 (TNKS1) and tankyrase 2 (TNKS2) are two homologous proteins that
are gaining increasing importance due to their implication in multiple pathways and …

[HTML][HTML] Dihydroartemisinin suppresses proliferation, migration, the Wnt/β‑catenin pathway and EMT via TNKS in gastric cancer Corrigendum in/10.3892/ol …

Y Ma, P Zhang, Q Zhang, X Wang… - Oncology …, 2021 - spandidos-publications.com
Gastric cancer is a common malignancy worldwide. However, the molecular mechanisms
underlying this malignancy remain unclear and there are a lack of effective drugs. The …